TAM
PRQR icon

Tocqueville Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Tocqueville Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,500
Closed -$105K – 873
2016
Q1 		$105K Hold
21,500
– – ﹤0.01% 832
2015
Q4 		$187K Buy
+21,500
New +$247K ﹤0.01% 859

Other funds holding PRQR

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tocqueville Asset Management's PRQR Position: Q2 2016 in Review

Tocqueville Asset Management sold out of ProQR Therapeutics (PRQR) in Q2 2016, closing a stake of 21,500 shares — an estimated $105K sold.

Tocqueville Asset Management first reported a position in PRQR in Q4 2015 and held it in 2 quarters. The position peaked at $187K in Q4 2015. 26 funds tracked by Wall St. Rank hold PRQR as of Q2 2016.

  • Tocqueville Asset Management reported no remaining ProQR Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Tocqueville Asset Management sold 21,500 ProQR Therapeutics shares in Q2 2016, an estimated $105K.
  • Tocqueville Asset Management first reported a position in ProQR Therapeutics in Q4 2015 and held it in 2 quarters.
  • Tocqueville Asset Management's ProQR Therapeutics position peaked at $187K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2016.

Based on Tocqueville Asset Management's 13F filing for Q2 2016, filed 29 Jul 2016.